Case Studies

Kirsty carried out a work placement at Precision Medicine Scotland Innovation Centre (PMS-IC) as part of her MSc in Precision Medicine and Pharmacological Innovation, which she studied at the University of Glasgow. The one-year course is being developed in conjunction with PMS-IC and aims to create a highly trained workforce…

Dr Tim Kendall is part of a collaborative team from across Scotland who are currently working on the SteatoSITE project. SteatoSITE is a unified data system that allows sharing of genomic and clinical information from patients with NASH – the progressive form of non-alcoholic fatty liver disease (NAFLD) – making…

Ovarian cancer is often known as the ‘silent killer’, because its symptoms can be mistaken for other less harmful conditions, or simply put down to changes in the body due to ageing. This means around 7 in 10 cases are diagnosed at a late stage, by which time the cancer…

What project is currently taking up most of your time?   In February this year, we were awarded a £1.7M collaborative grant from Innovate UK for a ground-breaking project that could help develop new tests and treatments for patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is an accumulation of…

It is very aggressive and can be difficult to diagnose, as often it doesn’t cause many symptoms in the early stages. Tumours also give different symptoms depending on where in the pancreas they are located. Because of this, it tends to be diagnosed at a later stage, when it is…

Scotland has one of the highest rates of multiple sclerosis (MS) in the world, with around 10,000 people living with this debilitating condition. It is thought that it is caused by a combination of genetic and environmental factors. There is no cure for MS, which affects nerves in the brain…